← Browse by Condition
Medical Condition
gastroesophageal junction adenocarcinoma
Total Trials
7
Recruiting Now
7
Trial Phases
Phase 2, Phase 3, Phase 1, Phase 2, Phase 3
ClinicalMetric tracks all active clinical trials for gastroesophageal junction adenocarcinoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — gastroesophageal junction adenocarcinoma Clinical Trials
How many clinical trials are currently recruiting for gastroesophageal junction adenocarcinoma?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for gastroesophageal junction adenocarcinoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for gastroesophageal junction adenocarcinoma?
gastroesophageal junction adenocarcinoma research spans Phase 1 (3 trials), Phase 2 (4 trials), Phase 3 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a gastroesophageal junction adenocarcinoma clinical trial?
Eligibility criteria for gastroesophageal junction adenocarcinoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 3
Phase 2 4
Phase 3 2
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06028737 Phase 2, Phase 3
Recruiting
Enrollment
150 pts
Location
Lithuania, Ukraine
Sponsor
Ukrainian Society of Clinical ...
NCT07818018 Phase 1, Phase 2
Recruiting
Enrollment
30 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
NCT07518147 Phase 3
Recruiting
Enrollment
438 pts
Location
China
Sponsor
Biokin (Shanghai) Biopharmaceu...
NCT06038578 Phase 2
Recruiting
Enrollment
146 pts
Location
United States, Japan...
Sponsor
Toray Industries, Inc
NCT06131840 Phase 1
Recruiting
Enrollment
914 pts
Location
United States, Canad...
Sponsor
Seagen, a wholly owned subsidi...
NCT07072351 Phase 1, Phase 2
Recruiting
Enrollment
88 pts
Location
China
Sponsor
West China Hospital
NCT04850729
Recruiting
Enrollment
169 pts
Location
China
Sponsor
Nanfang Hospital, Southern Med...
Related Conditions
gastric cancer (4) gastric adenocarcinoma (3) advanced gastroesophageal junction adenocarcinoma (2) chemotherapy (2) stomach cancer (1) gastroesophageal cancer (1) advanced gastric adenocarcinoma (1) gastric neoplasm (1) stomach neoplasm (1) gastrointestinal cancer (1) advanced gastric carcinoma (1) gastrectomy (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology